• S&P 500 ATH 7,230 and Nasdaq 25,000 first-ever close — best April for major indices since 2020; S&P +1.02% single session Thursday as GOOGL (+10%), CAT (+9.88%), LLY (+9.80%), QCOM (+15%) swept earnings day.

• INTC +20.69% WoW — week’s top mega-cap gainer as the AI/CPU renaissance thesis compounded through five sessions; MU (+9.16%) and LLY (+8.98%) completed the gainers podium driven by AI memory demand and GLP-1 dominance respectively.

• GOOGL +10% Thursday / META −8.65% same session — the week’s defining AI bifurcation: Cloud +63% revenue growth rewarded; $145B capex raise without equivalent revenue proof punished. The “show me the money” era arrived at the highest-stakes possible moment.

• WTI +7.94% WoW / Brent intraday $126 Wednesday as Trump confirmed months-long Iran naval blockade; UAE exited OPEC after 60 years Friday; US gasoline hit $4.30/gal (4-year high); IEA called it “the largest oil supply disruption in history.”

• FOMC 8-4 historic split — most divided vote since 1992 (two-directional dissent); rate-cut probability collapsed from 59% to ~22.5% in a single week; Kevin Warsh advanced 13-11 through Senate Banking on strict party lines.

• Stagflation data suite landed in one week: Core PCE 3.2% YoY, GDP +2.0% (composition fragile), ECI +0.9% (3-quarter high), ISM Prices Paid 84.6% (4-year high), Employment 46.4% (deepest 2026 contraction) — versus jobless claims 189K (55-year low) as the sole bullish outlier.

1. AI Capex Enters the “Show Me the Revenue” Era — After years of rewarding hyperscaler AI spending on faith, this week drew the market’s first clear bifurcation: GOOGL (Cloud +63% YoY, capex raised and rewarded with +10%) vs. META (capex raised $10B to $145B without equivalent revenue proof, punished −8.65%). The threshold was crossed at the highest-stakes possible moment — the same week $725B in combined 2026 capex was confirmed across all four hyperscalers. The implication extends across every AI-heavy company: demonstrated revenue ROI is now the prerequisite for multiple expansion, not just the destination.

2. The Stagflation Bind Is Now Empirically Confirmed, Not Forecast — One week delivered PCE 3.5% headline, Core PCE 3.2%, ECI re-acceleration to +0.9%, ISM Prices Paid 84.6%, and ISM Employment contraction to 46.4% — all while jobless claims hit a 55-year low of 189K. The Fed cannot cut (inflation too high) and cannot hike (growth fragile, employment uncertainty rising). This is not a tail risk scenario; it is the current data state that the incoming Warsh Fed will inherit on May 15 alongside a fractured 8-4 committee without consensus on direction.

3. Hormuz Is No Longer a Geopolitical Spike — It Is a Structural Supply Constraint — The IEA confirmed full Hormuz reopening would not restore Middle East output to pre-war levels for up to two years; the UAE’s exit from OPEC after 60 years added a second structural dimension. Energy is no longer a cyclical trade — it is a fundamental portfolio allocation decision with a supply/demand framework that persists whether the Iran conflict resolves in weeks or years, and with the UAE’s unconstrained production expansion creating an asymmetric medium-term downside risk that the current $100+ price level does not yet reflect.

FOMC Votes 8-4 to Hold — Most Divided Since 1992; Two-Way Dissent Eliminates Forward Guidance (Federal Reserve, April 29, 2026)

What they’re saying:The FOMC voted 8-4 to hold the federal funds rate at 3.50%–3.75% for the third consecutive meeting — the most dissents since 1992. Three hawkish dissenters (Hammack, Kashkari, Logan) opposed retaining any easing bias; one dovish dissenter (Miran) demanded a 25 bps cut. The statement upgraded inflation language from “somewhat elevated” to “elevated,” explicitly citing Middle East energy prices. Chair Powell stated cuts are “not on the agenda” as long as the economy continues to grow, and confirmed he will remain on the Board of Governors through 2028. CME FedWatch moved to 77.5% probability of no rate cuts through year-end 2026.

The context:A two-directional dissent — one member demanding immediate cuts, three demanding tighter guidance — is historically unusual and signals a committee at a genuine crossroads. For the rate path, this eliminates the predictable Fed backstop that supported equity multiples through 2024–2025. With Kevin Warsh expected to take the chair on May 15, the incoming leadership inherits not just a stagflation data backdrop but a fractured committee with no consensus on direction. Warsh’s “regime change” preferences (trimmed-mean inflation gauge, aggressive balance-sheet reduction) add policy uncertainty on top of the FOMC split. (Rate-cut probability −36.5 pp WoW — see Polymarket table above; 10Y yields +6.6 bps WoW — see Vol & Treasuries table in Section B.)

What to watch:Warsh full Senate confirmation (week of May 11) and his inaugural rate-path statements — any explicit alignment with the three hawkish dissenters would immediately price in balance-sheet runoff acceleration. Watch 5Y5Y forward inflation breakeven for any further unanchoring signal beyond the FOMC’s own inflation language upgrade.

Q1 GDP +2.0% / Core PCE 3.2% / GDP Price Index +4.5% / ECI +0.9% — Stagflation Data Suite Confirms the Bind (BEA / BLS, April 30, 2026)

What they’re saying:Thursday’s BEA advance Q1 GDP: +2.0% SAAR (below 2.3% consensus; beat the Atlanta Fed’s final 1.2% GDPNow). Growth composition: private investment (core capex +3.29%, best since June 2020), consumer spending (+1.6% real), and government outlays (defense and shutdown reversal). GDP Price Index +4.5% QoQ (above +3.8% estimate). Core PCE March: +3.2% YoY / +0.3% MoM (in-line). Headline PCE: +3.5% YoY. Employment Cost Index Q1: +0.9% QoQ (beats +0.8% estimate; accelerates from +0.7% in Q4 2025 — highest quarterly wage cost growth in three quarters).

The context:The GDP composition is the critical caveat: a significant share of the Q1 rebound reflects the reversal of Q4’s federal government shutdown drag and elevated defense outlays linked to the Iran conflict. Strip those transient factors and organic private-sector growth was considerably softer. The ECI’s acceleration to +0.9% is the most troubling element: labor costs re-accelerating while manufacturing employment contracts (ISM Employment 46.4%) sets up a second-round inflation dynamic — exactly the scenario that prevented the Volcker Fed from easing in 1980–81. The PCE’s +3.5% headline and +3.2% core confirm inflation is running 120 bps above the Fed’s 2% target without any near-term convergence trajectory.

What to watch:April PCE (released May 30) — the first read on whether the Brent surge (+0.6pp estimated by Powell) is showing up in headline; if April PCE exceeds 4.0% headline, rate-hike probability will accelerate. Q1 GDP first revision (late May) for whether the defense/shutdown-reversal factors look as transient as assumed.

ISM Manufacturing Prices Paid 84.6% (4-Year High) / Employment 46.4% — Factory-Floor Stagflation Crystallized (ISM, May 1, 2026)

What they’re saying:The April ISM Manufacturing PMI held at 52.7% (matching March; fourth consecutive month in expansion), but the sub-indices told a sharply different story. Prices Paid jumped 6.3 points to 84.6% — the highest since April 2022, driven by tariff-related import cost surges. Employment Index fell 2.3 points to 46.4% — the deepest manufacturing job-loss reading of 2026, well below the 49.0 estimate. New Orders edged up to 54.1 from 53.5 (expansion). The Atlanta Fed trimmed its Q2 2026 GDPNow to 3.5% from 3.7% immediately following the release.

The context:The Prices Paid / Employment split is the starkest single-release stagflation data point of 2026. Fed research has quantified tariff pass-through at 3.1% on core goods PCE prices through late 2025; ISM Prices at 84.6% approaching their 2021 record highs implies that wave is re-accelerating into spring 2026. Simultaneously, manufacturing employment contracting for the third consecutive month signals factories are absorbing cost shocks through headcount reductions, not revenue recovery — the sequence that precedes broader labor market deterioration. The incoming Warsh Fed will confront this data on day one: ISM Prices too hot to cut; ISM Employment too weak to hike.

What to watch:ISM Services PMI (May 5, consensus 54.0) — specifically the Services Prices sub-index (prior 70.7%); if Services Prices approach manufacturing’s 84.6%, cost-push inflation has fully crossed the economy and the Fed’s last remaining cut optionality is removed. May ISM Manufacturing Employment for whether the contraction is deepening or stabilizing.

Initial Jobless Claims Plunge to 189K — Lowest Since 1969, Demolishing 215K Forecast; Labor Market Not Yet Breaking (DOL, April 30, 2026)

What they’re saying:Initial jobless claims fell 26,000 to 189,000 for the week ending April 25 — the lowest level in more than 55 years (since November 1969) — shattering the 215,000 forecast. The 4-week moving average also declined to 207,500, confirming the drop is not a one-week aberration. Continuing claims: 1,785K vs. 1,820K expected. A sub-200K reading has occurred fewer than a dozen times in the past decade.

The context:Claims at 189K is the week’s cleanest bullish outlier against an otherwise stagflationary data stack. For the Fed, a labor market this tight complicates any argument for early rate cuts — particularly against 3.5% PCE and 84.6% ISM Prices. The “low-hire, low-fire” dynamic that has characterized 2026 — where employers are neither shedding workers aggressively nor adding them — is sustaining the labor market without generating the demand-side growth momentum that would justify continued Fed optimism. The tension: ISM Manufacturing Employment at 46.4% (contraction) vs. claims at a 55-year low suggests manufacturers are cutting hours and freezing hiring rather than initiating mass layoffs — a leading indicator that often precedes formal payroll contraction by one to two quarters.

What to watch:April NFP (released Saturday May 2, consensus ~73K vs. March’s 178K) — the first hard payroll read to confirm or refute whether the ISM Employment contraction is spreading into actual layoffs. JOLTS Job Openings Mar (May 5) for the demand side of the labor equation.

Recession Odds Structurally Elevated: Goldman 30%, Moody’s 48.6%, Wilmington Trust 45% — GDP Miss Provides No Relief to Institutional Models (Multiple Sources, Week of Apr 27, 2026)

What they’re saying:Despite the S&P 500 reaching all-time highs and Q1 GDP printing +2.0%, institutional recession probability models showed no relief across the week. Goldman Sachs holds its 12-month US recession probability at 30% (raised from 25% on re-priced oil and lower GDP trajectory). Moody’s Analytics ML model sits at 48.6% — chief economist Zandi stated this is “historically the highest the model has registered without a recession following.” Wilmington Trust: 45%. EY-Parthenon: 40%. Prediction markets remain below institutional models: Polymarket 24% (down 2pp WoW), Kalshi ~33%.

The context:The institutional/prediction-market divergence — Goldman/Moody’s at 30–48.6% vs. Polymarket at 24% — reflects a structural disagreement between bottom-up models (which see deteriorating data) and market-derived probabilities (which see record equity prices). Historically, when institutional models and prediction markets have diverged by 20+ percentage points, the institutional side has been “early rather than wrong.” The Q1 GDP composition — propped by defense spending and shutdown reversal — did nothing to reduce Goldman’s or Moody’s estimates. The week’s stagflation data suite (PCE 3.5%, ECI +0.9%, ISM Prices 84.6%, Employment 46.4%) adds inputs that point in the same direction as the institutional models.

What to watch:Goldman and Moody’s probability updates following May 2 employment data — a miss below 100K NFP would likely push Goldman above 35% and Moody’s above 50%. May CPI (May 13) for whether energy pass-through is accelerating; Polymarket recession odds as the leading-indicator gap to watch.

1. Alphabet (GOOGL): +12% WoW | Q1 Revenue +22% YoY, Google Cloud +63% YoY — AI Monetization Arrives

The Numbers:Q1 2026 revenue $109.9B (+22% YoY; +2.7% beat vs. ~$107B est.); 11th consecutive double-digit revenue growth quarter. Net income $62.6B (+81% YoY). EPS $5.11. Google Cloud revenue $20.0B (+63% YoY) — first quarter where enterprise AI solutions cited as primary Cloud growth driver. Gemini Enterprise paid MAUs +40% QoQ. YouTube advertising $9.88B. Capex guidance raised to $180–190B (from $175–185B). Released: AMC April 29.

The Problem/Win:Cloud +63% at $20B quarterly revenue is the most definitive AI-monetization print of the hyperscaler cycle — not just spending on AI infrastructure but actual enterprise revenue growth driven explicitly by AI workloads. The 81% net income surge confirms operating leverage is real, not a financial engineering artifact. Gemini Enterprise MAU growth of 40% QoQ is the leading indicator that AI adoption conversion rates are accelerating. The raised capex guidance, unlike META’s punished raise, was rewarded because it was paired with commensurate revenue acceleration: investors can see the ROI.

The Ripple:GOOGL reclaimed the narrative in the cloud AI race, directly contrasting with Microsoft’s Azure +40% (strong but smaller) and positioning Google Cloud as the fastest-growing major enterprise cloud platform. Alphabet’s market cap surged toward $5T (closing within ~$320B of Nvidia’s #1 position). The +10% session drove the Nasdaq 100 to its first-ever 25,000 close. J.P. Morgan raised PT to $460 (Overweight).

What It Means:GOOGL’s quarter is the single most important datapoint in the AI investment thesis: the first major quarter where AI infrastructure spending demonstrably converted into enterprise revenue at scale. At 63% Cloud growth and 40% Gemini enterprise MAU growth, the monetization flywheel is turning faster than any prior consensus estimate.

What to watch:Q2 2026 Google Cloud growth guidance — sustaining above 50% YoY is the threshold to defend the current premium multiple. Google’s custom TPU expansion as an internal NVDA alternative for AI workloads.

2. Eli Lilly (LLY): +9.80% | Mounjaro $8.66B (+125% YoY) — GLP-1 Revenue Ramp Tracking Toward Largest in Pharma History

The Numbers:Q1 2026 revenue $19.80B (+56% YoY) vs. $17.82B estimate (+11.1% beat). EPS $8.26 vs. $6.97 estimate (+18.5% beat). Mounjaro worldwide $8.66B (+125% YoY) — $1.4B beat vs. consensus. Zepbound US $4.16B (+79% YoY). US GLP-1 combined unit volume +49% YoY. International Mounjaro +95% volume growth. FY2026 guidance raised: revenue $82–85B (from $80–83B), adj. EPS $35.50–$37.00. Released: BMO April 30.

The Problem/Win:Mounjaro’s $8.66B quarterly run rate puts it on pace for a $35B+ annualized franchise — a number that would make it the highest-revenue prescription drug in history within two years. The $1.4B beat vs. consensus is not a rounding error; it reflects genuine demand acceleration that the best sell-side models underestimated. The international geographic rollout is just beginning (Mounjaro +95% volume internationally), providing a second growth phase beyond the US market which has already absorbed significant saturation risk.

The Ripple:LLY’s print drove a healthcare sector +2.26% session on Apr 30 (a reversal from its structural −4.64% YTD trajectory). The FDA compounding exclusion proposal (May 1) added a regulatory moat dimension that the earnings alone didn’t capture — together the two events in a 36-hour window represent the strongest combined fundamental/regulatory week for GLP-1 names since the category launched. Novo Nordisk benefits from the same FDA compounding protection.

What It Means:LLY’s raised guidance to $82–85B in full-year revenue, with the FDA removing the compounded-drug competitive discount, positions Eli Lilly with both the demand confirmation (Mounjaro +125% YoY) and the regulatory protection needed to sustain premium pricing. The risk-adjusted case for LLY is compelling; the risk is Q2 guidance revealing whether $8.66B was a one-time inventory beat or the new baseline.

What to watch:Q2 Mounjaro revenue — whether the $8.66B quarterly level is sustained confirms the thesis; a sequential decline would raise inventory-pull questions. FDA compounding exclusion finalization timeline.

3. Amazon (AMZN): +4% AH | AWS +28% (15-Quarter Growth High) — EPS Crushes Estimates by 70.6%; Cloud Reacceleration Confirmed

The Numbers:Q1 2026 revenue $181.5B (+17% YoY) vs. $177.3B estimate (+2.4% beat). EPS $2.78 vs. $1.63 estimate (+70.6% beat — the largest EPS surprise among >$100B companies this quarter). AWS revenue $37.6B (+28% YoY, accelerating from +24% prior quarter) — fastest growth in 15 quarters. Q2 revenue guidance $194–199B. FY2026 capex $200B. Q1 backlog $364B (excludes $100B Anthropic deal). Released: AMC April 29.

The Problem/Win:The 70.6% EPS beat is the quarter’s most compelling number — it reflects both operating leverage in retail (margin expansion) and AWS margin acceleration as AI workloads scale on higher-value infrastructure. AWS reaccelerating to +28% from +24% eliminates any concern about cloud deceleration and validates the $200B capex commitment as demand-driven. The $364B backlog (plus the $100B Anthropic deal excluded from that figure) provides multi-year revenue visibility that Microsoft and Google don’t yet match at this scale.

The Ripple:AMZN’s AWS reacceleration frames the hyperscaler cloud race as genuinely competitive — Azure +40% (Microsoft) and Cloud +63% (Google) are faster in percentage terms, but AWS’s absolute scale ($37.6B quarterly) and reacceleration arc is the most compelling sequential trend. The 70.6% EPS beat also reinforces the retail segment’s operational recovery, providing diversification from the AI/cloud narrative.

What It Means:Amazon’s is the most balanced hyperscaler quarter: massive investment ($200B), accelerating revenue growth (AWS +28%), and explosive EPS leverage (+70.6%). The combination argues for AMZN as the cleanest large-cap AI beneficiary alongside GOOGL for investors seeking both AI revenue confirmation and fundamental earnings quality.

What to watch:Q2 AWS growth trajectory — whether +28% can sustain or whether it moderates as the base effect builds. Anthropic commercial milestones — the $100B deal excluded from backlog becomes the most watched line item in future quarters.

4. Meta Platforms (META): −9.82% WoW | Revenue +33% Beat, But $145B Capex Raise Without Revenue Clarity Triggered “Show Me the Money” Repricing

The Numbers:Q1 2026 revenue $56.31B (+33% YoY) vs. $55.56B estimate (+1.3% beat). Adjusted EPS $7.31 vs. $6.67 estimate (+9.6% beat). GAAP EPS $10.44 (includes $8.03B tax benefit from One Big Beautiful Bill Act). Family DAP: 3.56B (+4% YoY). Ad impressions +19%; avg. price per ad +12%. Capex guidance raised to $125–145B (from $115–135B) due to “higher component pricing and additional data center costs.” Q2 revenue guide $58–61B. Released: AMC April 29. Regular-session reaction: −8.65% Thursday.

The Problem/Win:The core tension: Meta beat on revenue and adjusted EPS, its ad AI targeting is demonstrably working (+19% impressions, +12% price), yet the market punished the stock −8.65% on the third consecutive quarter of capex escalation without a clear near-term revenue proof. Unlike Alphabet, which paired $180–190B capex with Cloud +63% YoY revenue, Meta’s $145B capex is primarily defensive (recommendation algorithms, Llama open-source) and monetization from Meta AI remains unquantified in the financials. The $8.03B GAAP tax benefit from the One Big Beautiful Bill Act also inflated GAAP EPS, masking underlying earnings quality relative to the adjusted figure.

The Ripple:META’s −8.65% session was the primary drag on the Nasdaq and Technology sector on Apr 30, even as GOOGL surged +10% the same day — the bifurcation within Communication Services (META is in the same sector as GOOGL) was striking. The combined hyperscaler $725B capex signal is a positive for NVDA, AVGO, and AI infrastructure suppliers; the META-specific punishment signals investors will increasingly differentiate between capex with proven ROI and capex on faith.

What It Means:META’s quarter marks the inflection point where the market shifted from “reward all AI spending” to “reward AI spending with proven returns.” Until Meta can demonstrate that $145B in capex generates commensurate advertising or Meta AI revenue, the stock will face multiple compression on any future capex announcement.

What to watch:Q2 Meta AI monthly active users and any monetization announcement; Llama API revenue disclosure; Ray-Ban Meta AI engagement metrics. Any capex deceleration signal would be the most powerful positive catalyst for META.

5. Apple (AAPL): +3.24% | Record $111.2B Revenue (+17% YoY), Services All-Time Record $30.98B, China +28% — $100B Buyback Added

The Numbers:Q2 FY2026 revenue $111.18B (+17% YoY) vs. $109.66B estimate (+1.4% beat). EPS $2.01 vs. $1.95 estimate (+3.1% beat). Services $30.98B (all-time record). iPhone $56.99B (record March quarter). Mac $8.4B, iPad $6.91B (both beat). Gross margin 49.3% vs. 48.4% estimate (significant beat). Greater China revenue $20.5B (+28% YoY). New $100B share buyback authorized; dividend raised to $0.27/share. Released: AMC April 30.

The Problem/Win:Apple delivered a broad-based beat: revenue, EPS, Services, Mac, iPad, and gross margin all topped estimates. The gross margin beat (49.3% vs. 48.4% est.) is the most important number — it implies either better-than-expected supply chain management or favorable Services mix shift, and it directly informs free cash flow quality for sustaining the $100B buyback. The China +28% recovery is strategically critical: a market investors had largely written off for two years is now re-engaging with the iPhone 17 cycle, potentially adding several hundred million dollars in incremental revenue. The $100B buyback is the largest single authorization in Apple’s history and provides a durable price floor.

The Ripple:Apple’s +3.24% session on Fri capped the week’s mega-cap earnings sweep (GOOGL, AMZN, CAT, LLY, AAPL all meaningful beats), confirming the breadth of Q1 corporate performance. The China recovery is a positive read-through for other US consumer tech with China exposure. The iPhone record March quarter validates the AI device upgrade cycle thesis, partially pre-empting the competitive narrative from the OpenAI-Qualcomm smartphone partnership announced earlier in the week.

What It Means:Apple completed the week’s earnings story: the hardware device cycle is intact, Services are compounding, and China is recovering. At a $3.97T market cap, the $100B buyback (~2.5% of market cap) provides meaningful support while management signals confidence in cash generation durability at elevated gross margins.

What to watch:Q3 FY2026 revenue guidance — if management implies mid-to-high teens growth, the iPhone 17 cycle is intact; any caution on guidance signals the China recovery is fragile. Apple Intelligence feature adoption metrics as a Services growth catalyst.

Q1 2026 earnings season has crossed 63% of the S&P 500 reported. The coming week is lighter in mega-cap volume but includes several noteworthy events led by Berkshire Hathaway’s first full earnings cycle under Greg Abel as CEO.

Berkshire Hathaway (BRK-B) — BMO Saturday May 2 (markets react Monday May 4) — Key focus: Greg Abel’s first full earnings cycle as CEO; whether the $373.3B cash hoard was deployed in Q1 or maintained; insurance underwriting profitability in a relatively benign catastrophe quarter; any commentary on the macro environment and tariff/oil-cost impact on Berkshire’s industrial and consumer subsidiaries. Annual shareholders meeting Saturday in Omaha. Revenue est. $95.1B (+6%), EPS est. $4.82.

Palantir Technologies (PLTR) — AMC Monday May 4 — Key focus: AIP (AI Platform) commercial customer count and contract velocity; US government contract momentum (US gov revenue grew 55% YoY in 2025); full-year 2026 revenue guidance (analysts expect ~74% growth to $1.54B). Pentagon’s mass AI clearance announcement Friday — which explicitly named Palantir as a cleared vendor — makes this earnings report particularly watched. Options market pricing a ~10.55% move in either direction.

Vertex Pharmaceuticals (VRTX) — AMC Monday May 4 — Key focus: JOURNAVX (suzetrigine) prescription trajectory; Casgevy (sickle cell / beta thalassemia cell therapy) launch metrics; any pipeline update on APOL1-mediated kidney disease. Revenue est. $2.99B, adj. EPS est. ~$4.24.

1. Does ISM Services confirm the stagflation has crossed the full economy? Manufacturing’s Prices Paid hit 84.6% this week while Employment contracted to 46.4%. If Services Prices (currently 70.7%) rise alongside Employment contraction (currently 45.2%), the cost-push wave has fully absorbed both sectors simultaneously — locking the incoming Warsh Fed into a structural bind with no clean policy path before it has even held its first meeting. That scenario would likely force a public acknowledgment from Warsh that tightening (not just holding) is a realistic 2026 option.

2. Will April NFP confirm or contradict the ISM Employment deterioration? The consensus for April NFP (released Saturday May 2) is ~73K — less than half of March’s 178K. If payrolls come in below 100K, the labor market is in genuine deceleration rather than “low-hire, low-fire” stasis, and the recession models at Goldman (30%), Moody’s (48.6%), and Wilmington (45%) face immediate upward revision. That would be the data that forces the FOMC into visible discomfort: hot PCE preventing cuts, softening payrolls preventing hikes.

3. How does Warsh’s confirmation posture land on the stagflation/rate-path debate? The Senate Banking vote passed 13-11 on party lines — the most partisan Fed chair vote in committee history. Warsh’s confirmation is near-certain, but his first public statements will define how aggressively he aligns with the three hawkish dissenters (Hammack, Kashkari, Logan) who sought to remove the easing bias entirely. A Warsh statement that frames “no hikes for now but no cuts either” lands very differently from one that signals balance-sheet runoff acceleration — the 10Y yield and duration assets will react within hours of any public remarks.

4. Can Palantir’s earnings quantify the DoD AI contract TAM opened by the Pentagon clearance? Friday’s announcement cleared Palantir for Impact Level 6/7 classified military networks — the highest-tier DoD AI deployment. PLTR reports Monday AMC with options pricing a ~10.55% move. Any dollar disclosure on classified contract pipeline value, or raised FY2026 guidance that implies acceleration beyond the current ~74% growth consensus, would be the first financial quantification of the defense AI TAM opened by this week’s Pentagon action.

Chart of the Week: The week that delivered Nasdaq 25,000 ATH records alongside ISM Manufacturing Prices at 84.6% and Employment at 46.4% — both at extremes in opposite directions — is exactly the divergence this SOX/ISM chart captures: semiconductor stocks pricing an AI demand supercycle while factory-floor employment contracts under tariff-driven cost pressure. Historical convergence between the two lines arrives through either a chip-sector correction or a genuine manufacturing renaissance; this week’s hyperscaler earnings blowouts briefly argued for the latter, but Friday’s ISM data argued back with equal force — and the resolution is the defining macro question heading into May.